Zydus receives final approval from USFDA for Eluxadoline Tablets, 75 mg and 100 mg
Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea
Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea
The programme will take place on the 2nd Sunday of every month
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections
The MDR certification reafirms that these products meet the highest safety, quality, and regulatory standards
The European regulator will conduct a re-inspection of the facility to verify the compliance
Announces Rs. 317 crore investment in new recycling plant
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
Encourages working women to practice self-care
Subscribe To Our Newsletter & Stay Updated